Global Botulinum Toxin Market To Exhibit Significant Growth By 2025 Owing To Widening Application Area | Grand View Research, Inc.

Global Botulinum Toxin Market To Exhibit Significant Growth By 2025 Owing To Widening Application Area | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
As per the report by Grand View Research, Inc., the global Botulinum Toxin market is also hit by COVID-19 like many other industries. Due to the lockdown, people suffering from spasticity couldn’t go to the hospitals for BoNT-A treatment. Because of this, many people’s conditions got worse.

The global Botulinum Toxin Market was valued at USD 3.4 billion in 2015 and is expected to grow at a CAGR of 7.9% over the forecast period according to the report published by the Grand View Research, Inc. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market. In addition, the rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stays, and rapid wound healing, and hence lead to larger acceptance and demand.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in the therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval to treat strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperhidrosis, cervical dystonia, upper limb spasticity, chronic migraine, and urinary incontinence in 2009, 2010, and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period. Recently, Aquavit Holdings LLC introduced a new botulinum toxin (DTX-021) for the aesthetic market. With the help of the exclusive license, the Korean firm will be able to register, market, and commercialize this new BNT in Canada and the United States. 

Botulinum Toxin Market Report Highlights

 The botulinum toxin type A segment had the largest share in 2015 and is also expected to be the fastest-growing segment during the forecast period.

 Botulinum toxin is widely used for aesthetic purposes as it helps in improving facial appearance and decreasing signs of aging, thus, the aesthetic segment had the largest share in 2015.

 North America captured the largest revenue share in 2015, as it has a large population having higher disposable income. Also, North America has many aesthetic procedures available to them, which are pushing the demand in this region.

 As social awareness regarding anti-wrinkle procedures is growing in the Asia Pacific, this region is anticipated to be the fastest-growing region during the forecast period.

 Major players in this market are Allergan, Inc.; Ipsen Group; Merz GmbH, and Co. KGaA, Medytox, Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

For Requesting a Sample Copy of This Report, Please Visit @

Botulinum Toxin Market Segmentation

Grand View Research has segmented the botulinum toxin market by type, end use, and region:

Product Type Outlook (Revenue, USD Million; 2013 – 2025)

    Botulinum Toxin Type A
    Botulinum Toxin Type B

End-use Outlook (Revenue, USD Million; 2013 – 2025)


Regional Outlook (Revenue, USD Million; 2013 – 2025)

     North America
        • The U.S.
        • Canada
    • Europe
        • Germany
        • The U.K.
    • Asia Pacific
        • China
        • India
    • Latin America
        • Mexico
        • Brazil
    • Middle East & Africa
        • South Africa

Speak to Analyst @

Browse More Related Report:

Migraine Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Triptans, CGRP-based Therapies, Ditans, Neurotoxins, NSAIDs), By Treatment, By Route Of Administration, And Segment Forecasts, 2018 – 2025

Neuroendocrine Tumor Treatment Market Size, Share & Trends Analysis Report By Site (Small Intestine, Pancreas), By End Use (Hospitals, Clinics), By Product (SSA, Targeted Therapy), And Segment Forecasts, 2018 – 2025

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company headquartered in San Francisco, which offers syndicated research reports, customized research reports, and consulting services. The company’s rich database includes in-depth analysis across a range of industries including chemicals, materials, energy, healthcare, and technology, among others.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States